A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/138 (2006.01) A61K 31/337 (2006.01) A61K 31/704 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2497180
An improved adjuvant treatment of metastatic breast cancer in which patients are administered an anthracycline chemotherapeutic agent and a taxane chemotherapeutic agent is provided in which a diphenyl compound which is a potent antagonist of histamine binding at the intracellular histamine receptor is initially administered prior to administration of the chemotherapeutic agents.
L'invention concerne un traitement adjuvant du cancer du sein métastatique, qui consiste à administrer au patient un agent chimiothérapeutique aux anthracyclines et un agent chimiothérapeutique aux taxanes, et à lier un composé diphényle, antagoniste puissant de l'histamine, avec le récepteur de l'histamine intracellulaire, qui est d'abord administré préalablement à l'administration des agents chimiothérapeutiques.
Sim & Mcburney
The University Of Manitoba
LandOfFree
Treatment of metastatic breast cancer with anthracyclines,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of metastatic breast cancer with anthracyclines,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of metastatic breast cancer with anthracyclines,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1984382